Magnetization Transfer Imaging in Neurodegenerative Disorders

Magnetization transfer imaging exploits the exchange of magnetisation between free water protons and those bound to macromolecules, providing indirect measures of tissue microstructure. Quantitative metrics such as bound pool fraction and macromolecular proton fraction enable in vivo assessment of myelin integrity and macromolecular content. In neurodegenerative disorders—most notably multiple sclerosis, Alzheimer’s disease and related dementias—these metrics furnish sensitive biomarkers of demyelination, tissue remodelling and disease progression. By detecting subtle alterations in proton pools before conventional imaging detects overt lesions, magnetization transfer imaging holds promise for early diagnosis, monitoring therapeutic response and tailoring personalised interventions. Advances in pulse‐sequence design and modelling now permit whole‐brain coverage within clinically acceptable timeframes, enhancing the technique’s translational potential across diverse patient populations and research settings.

Research from Nature Portfolio

Recent ex vivo work on porcine spinal cord white matter has clarified orientation‐dependent longitudinal relaxation and magnetization transfer anisotropy. By rotating samples relative to the main magnetic field and comparing inversion‐recovery, MP2RAGE and variable flip‐angle measurements, researchers demonstrated that magnetization transfer contributions underpin variations in T1 with fibre‐to‐field angle. This insight refines interpretation of in vivo anisotropic contrast and informs protocol design for human studies.

A foundational histological validation using the cuprizone demyelination model confirmed that fast macromolecular proton fraction mapping correlates strongly with myelin staining across white and grey matter regions. Quantitative proton fraction estimates matched Luxol Fast Blue histology, underscoring the technique’s robustness for quantifying both de- and remyelination. These findings establish macromolecular proton fraction as a reliable surrogate marker for preclinical and clinical trials of myelin-targeted therapies.

Magnetization Transfer Imaging in Neurodegenerative Disorders publication trend

The graph below shows the total number of articles in magnetization transfer imaging in neurodegenerative disorders across all publications each year (not limited to Nature Index journals).

Technical terms

Magnetization Transfer (MT): The exchange of magnetisation between mobile water protons and macromolecular protons, generating contrast sensitive to tissue composition.

Macromolecular Proton Fraction (MPF): The proportion of protons bound to macromolecules relative to total proton pool, serving as a surrogate for myelin content.

Bound Pool Fraction (BPF): The fraction of semi-solid protons in tissue, directly linked to macromolecular density.

Semi-solid Spin Pool: Protons bound within macromolecular structures exhibiting restricted motion and contributing to MT contrast.

Free Pool: Mobile water protons whose longitudinal relaxation is modulated by exchange with the semi-solid pool.

Inhomogeneous MT (ihMT): A dual-frequency saturation approach enhancing myelin specificity by targeting distinct macromolecular resonances.

References

1. Anisotropic longitudinal water proton relaxation in white matter investigated ex vivo in porcine spinal cord with sample rotation. Scientific Reports (2024).
2. Histological validation of fast macromolecular proton fraction mapping as a quantitative myelin imaging method in the cuprizone demyelination model. Scientific Reports (2017).
3. Unconstrained quantitative magnetization transfer imaging: Disentangling T1 of the free and semi-solid spin pools. Imaging Neuroscience (2024).
4. Age-Related Decline in Brain Myelination: Quantitative Macromolecular Proton Fraction Mapping, T2-FLAIR Hyperintensity Volume, and Anti-Myelin Antibodies Seven Years Apart. Biomedicines (2023).
5. High‐frequency longitudinal white matter diffusion‐ and myelin‐based MRI database: Reliability and variability. Human Brain Mapping (2023).